RXST RxSight, Inc.
RxSight, Inc. (RXST) is expected to report earnings on February 2, 2027, after the market close. The consensus earnings estimate is $0.28 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +21.9% since its last earnings release on November 3, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.
Sector
Healthcare
Industry
Medical Instruments/Supply
Held By 1 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.